Tarsus Pharmaceuticals, Inc. is a forward-thinking clinical-stage biopharmaceutical company headquartered in Irvine, California, dedicated to developing groundbreaking therapies for ophthalmic diseases. The firm boasts an innovative pipeline, particularly targeting dry eye disease and other vision-related disorders, addressing critical unmet needs in the ophthalmology market. Through its steadfast commitment to advancing clinical trials and understanding ophthalmic market trends, Tarsus is strategically positioned for growth and to enhance patient outcomes within the evolving healthcare landscape. Show more

Location: 15440 LAGUNA CANYON ROAD, IRVINE, CA, UNITED STATES, 92618, Irvine, CA, 92618, USA | Website: https://www.tarsusrx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

2.74B

52 Wk Range

$38.51 - $85.25

Previous Close

$64.54

Open

$64.59

Volume

538,771

Day Range

$64.32 - $66.88

Enterprise Value

2.42B

Cash

112.7M

Avg Qtr Burn

N/A

Insider Ownership

3.04%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
XDEMVY (TP-03) Details Eye disease , Demodex Blepharitis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TP-05 Details Lyme disease	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TP-04 Details Ocular Rosacea	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TP-04 Details Papulopustular rosacea	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TP-03 Details Meibomian Gland Disease	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.